Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in

Giuliana Magri1, Mario Clerici, Paola Dall'Ara

  • 1Laboratory of Immunology, DSP LITA Vialba, Universita' degli Studi di Milano, Via G.B. Grassi 74, 20157 Milano, Italy.

Vaccine
|March 23, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-synuclein at the crossroads of host-virus interactions: immunological roles beyond the nervous system.

Journal of virology·2026
Same author

IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

The Journal of experimental medicine·2026
Same author

Environmental Occurrence of Potentially Pathogenic Bacteria in the Equine Anesthetic Induction and Recovery Box: A Single-Center Study.

Animals : an open access journal from MDPI·2026
Same author

Beyond the host: Unveiling the independent microbiome of equine gastrointestinal nematodes.

PloS one·2026
Same author

Epigenetic, histological and clinical characterization of preeclampsia in oocyte donation pregnancies: insights into immune dysregulation and microRNA-mediated pathways.

Frontiers in cell and developmental biology·2026
Same author

Revisiting the alpha-synuclein paradox in melanoma-Parkinson's disease connection: more than a tale of two cell fates.

Cellular and molecular life sciences : CMLS·2025

Vaccination using prion protein oligopeptides extended survival in hamsters with prion disease. This approach reduced brain pathology and pro-inflammatory cytokines, suggesting a potential therapy for prion diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Veterinary Medicine

Background:

  • Prion diseases are fatal neurodegenerative disorders with no effective treatments.
  • Recent successes in Alzheimer's disease (AD) models suggest vaccination may be a viable therapeutic strategy for neurodegenerative conditions.

Purpose of the Study:

  • To investigate the efficacy of vaccination with synthetic prion protein oligopeptides in a hamster model of prion disease (263K scrapie agent).
  • To evaluate the impact of this vaccination on survival time, prion protein deposition, neuroinflammation, and specific immune responses.

Main Methods:

  • Hamsters were vaccinated with synthetic oligopeptides homologous to the hamster prion protein.
  • Animals were infected intraperitoneally with the 263K scrapie agent.

Related Experiment Videos

  • Evaluated prion-specific serum antibodies, pathological prion protein (PrP(res)) deposition, glial fibrillary acidic protein (GFAP) expression, and cytokine mRNA (TNF alpha, IL-1beta, IL-10) in brain tissues.

    • Main Results:

    • Vaccination significantly augmented survival time in infected hamsters.
    • Immunized animals showed reduced cerebral lesion severity, decreased PrP(res) deposition, and lower GFAP expression in brain tissues.
    • Increased levels of anti-prion protein peptide antibodies and reduced expression of pro-inflammatory cytokines (TNF alpha, IL-1beta) were observed in vaccinated hamsters.

    Conclusions:

    • Vaccination with synthetic prion protein oligopeptides can be an effective therapeutic strategy to delay disease progression in prion diseases.
    • The observed reduction in neuropathology and neuroinflammation supports the potential of this approach for treating prion infections.